Barchart.com's Chart of the Day - HealthEquity
Related Stocks
 HQY - Healthequity
SymLastChgPct
HQY85.84-1.66-1.90%

The Barchart Chart of the Day belongs to medical services company HealthEquity (HQY). I found the stock by using Barchart to sort today's New 52 Week High list first for the most frequent number of new highs in the last month, then again for technical buy signals of 80% or more. I always use the Flipchart feature to review the charts for consistent price appreciation. Since the Trend Spotter signaled a buy on 8/10 the stock gained 17.51%.

HealthEquity, Inc. is a technology-enabled services platforms that empower consumers to make healthcare saving and spending decisions. The Company's platform provides an ecosystem where consumers can access their tax-advantaged healthcare savings, compare treatment options and pricing, evaluate and pay healthcare bills, receive personalized benefit and clinical information, earn wellness incentives, and make educated investment choices to grow their tax-advantaged healthcare savings. HealthEquity, Inc. is headquartered in Draper, Utah.

HQY

Barchart's Opinion Trading systems are listed below. Please note that the Barchart Opinion indicators are updated live during the session every 10 minutes and can therefore change during the day as the market fluctuates. The indicator numbers shown below therefore may not match what you see live on the Barchart.com website when you read this report.

Barchart technical indicators:

  • 88% technical buy signals
  • 129.00+ Weighted Alpha
  • 131.04% gain in the last year
  • Trend Spotter buy signal
  • Above its 20, 50 and 100 day moving averages
  • 17 new highs and up 23.76% in the last month
  • Relative Strength Index 84.20%
  • Technical support level at 91.98
  • Recently traded at 96.92 with a 50 day moving average of 82.64

Fundamental factors:

  • Market Cap $5.86 billion
  • P/E 123.96
  • Revenue expected to grow 23.50% this year and another 23.10% next year
  • Earnings estimated to increase 58.30% this year, an additional 26.92% nxt year and continue to compound at an annual rate of 32.27% for the next 5 years
  • Wall Street analysts issued 8 strong buy, 1 buy and 2 hold recommendations on the stock